Weekly Intravenous and Intraperitoneal Paclitaxel Combined with S-1 for Malignant Ascites due to Advanced Gastric Cancer

Publisher： Karger

E-ISSN： 1423-0232|78|1|40-46

ISSN： 0030-2414

Source： Oncology, Vol.78, Iss.1, 2010-03, pp. : 40-46

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I Pharmacokinetic Study of Weekly Intravenous and Intraperitoneal Paclitaxel Combined with S-1 for Advanced Gastric Cancer

By  

Oncology, Vol. 76, Iss. 5, 2009-03 ,pp. : 311-314

Karger

Access to resources Recommend Favorite

A phase 2 trial of intravenous and intraperitoneal paclitaxel combined with S‐1 for treatment of gastric cancer with macroscopic peritoneal metastasis

By  

CANCER, Vol. 119, Iss. 18, 2013-09 ,pp. : 3354-3358

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase I and Pharmacokinetic Study of S-1 Combined with Weekly Paclitaxel in Patients with Advanced Gastric Cancer

By  

Oncology, Vol. 69, Iss. 5, 2005-12 ,pp. : 414-420

Karger

Access to resources Recommend Favorite

Phase I Study of a Combination of S-1 and Weekly Paclitaxel in Patients with Advanced or Recurrent Gastric Cancer

By  

Oncology, Vol. 69, Iss. 3, 2005-10 ,pp. : 261-268

Karger

Access to resources Recommend Favorite

Phase I/II Study of a Combination of S-1 and Weekly Paclitaxel in Patients with Advanced or Recurrent Gastric Cancer

By  

Oncology, Vol. 72, Iss. 3-4, 2008-01 ,pp. : 219-225

Karger

Access to resources Recommend Favorite